Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene

29 Sept 2021

Abstract excerpt

MYBL2 has been demonstrated to be an oncogene in some cancers, but there is no pan-cancer analysis at the macro level. We used multiple online or offline bioinformatic tools to examine the effects of MYBL2 in human cancers. We first identified that MYBL2 was highly expressed and related to the stage and grade of most cancers. The results of survival analysis from two databases showed that high MYBL2 expression...

Topics

Join the communities discussing this publication.

Cancer-related Molecular Pathways
Ferroptosis and cancer prognosis
Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34585645
DOI: 10.1080/15384101.2021.1982494

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogenePMID 34585645Read ↗

MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesisSemantic proximity Read ↗

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read ↗

PKM2 modulates chemotherapy sensitivity by regulating autophagy and predicts the prognosis and immunity in pancancerSemantic proximity Read ↗

Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.Semantic proximity Read ↗

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-CancerSemantic proximity Read ↗

KMT2C is Potential Prognostic Biomarker and its Immune Regulating Roles in Pan-Cancer: A Comprehensive AnalysisSemantic proximity Read ↗

Pan-cancer analysis of BLM as a prognostic and immunological marker in human tumorsSemantic proximity Read ↗

The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis.Semantic proximity Read ↗

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor MicroenvironmentSemantic proximity Read ↗

CGB5 Proves to be a Promising Predictive and Immunotherapeutic Indicator across Pan-CancerSemantic proximity Read ↗

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-CancerSemantic proximity Read ↗

A Pan-cancer Analysis of Kelch Like Family Member 38 (KLHL38) Alterations in Human CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.